Explore and Visualize Paired Tumor / Normal samples from TCGA with Ease
Genomic data from The Cancer Genome Atlas (TCGA) project has enabled comprehensive molecular profiling of diverse cancer types. The extensive sample size within TCGA provides an invaluable resource for investigating tumor heterogeneity. Effective exploration of this dataset by researchers and clinicians is essential for discovering novel therapeutic and diagnostic biomarkers.
The R2Platform, provides an easy interface to explore the rich resource at different levels. By example, subset the cohort to paired tumor / normal patients only and discover how the expression of your gene of interest changes from normal to tumor.
The R2 data science platform for biomedical researchers serves as a robust tool for in silico validation of target genes and the identification of candidate biomarkers for tumor subtype-specific research. The R2 portal has the potential to accelerate cancer research by providing accessible and comprehensive analytical capabilities. R2 is already cited in more than 2700 Pubmed listed manuscripts. It is publicly available at https://r2.amc.nl.
Reacties
Een reactie posten